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Purpose:  To  investigate  whether  apoptosis  of  human  lens  epithelial  cells  (HLECs)  can  be  induced  with  the
polyamidoamine (PAMAM)-mediated inhibition of bcl-2 (b-cell lymphoma 2) by small hairpin RNA (shRNA).
Methods: HLECs (SRA01/04) were transfected with the fifth generation of PAMAM (PAMAM G5) by bcl-2 shRNA.
At 24, 48, and 72 h after transfection, the transfection rate was measured by flow cytometry. The transfection rates mediated
by PAMAM and liposome were compared. The bcl-2 mRNA level was detected by real-time PCR. Whole cell protein
was extracted and the bcl-2 protein level was detected by western blotting. The percentage of HLECs undergoing apoptosis
was measured by Annexin V-FITC/PI staining. The nuclear morphology of HLECs was observed by staining with Hoechst
33258. The expression of cytochrome c and the activity of cleaved caspase-3 were analyzed by western blotting.
Results: At 24, 48, and 72 h after transfection, the rate of transfection of bcl-2 shRNA mediated by PAMAM was higher
than in the liposome-mediated group (p<0.05). The mRNA and protein levels of bcl-2 were greatly downregulated. The
percentage of HLECs undergoing apoptosis was greatly improved. Hoechst staining showed that bcl-2 shRNA transfected
cells had a lower growth status with nuclear fragmentation. The expression of cytochrome c and the activity of cleaved
caspase-3 was greatly improved (p<0.05).
Conclusions: PAMAM-mediated bcl-2 shRNA can downregulate the expression of bcl-2 and induce the apoptosis of
HLECs by engaging the mitochondrial pathway, including catalytic activation of the caspases.
Posterior  capsule  opacification  (PCO)  is  the  most
common  complication  of  cataract  surgery  causing  visual
impairment.  The  main  cause  of  PCO  is  the  proliferation,
migration,  and  metaplasia  of  remnant  lens  epithelial  cells
(LECs)  after  cataract  surgery  [1-3].  Approaches  for  the
prevention  of  PCO,  such  as  the  improvement  of  surgical
techniques and intraocular lens (IOL) design and the use of
antiproliferative drugs, have greatly decreased the PCO rate.
However, the occurrence is still significant, at about 8%–
34.3% in adults and nearly 100% in children [4-8]. Therefore,
the development of an alternative therapy for preventing PCO
is  of  critical  importance.  Gene  therapy  provides  a  novel
strategy  for  the  treatment  of  PCO;  however,  the  present
methods have drawbacks in terms of efficiency and safety
[9-11].
RNA  interference  (RNAi)  has  been  one  of  the  most
exciting discoveries of the past few years. Since its discovery,
RNAi has shown great potential as a gene therapy [12,13]. In
our previous study, we successfully constructed two pairs of
bcl-2 (b-cell lymphoma 2) small hairpin RNAs (shRNAs) and
confirmed that both of them, transfected by liposome, could
inhibit  the  expression  of  bcl-2  in  human  LECs  (HLECs)
[14]. However, the low transfection efficiency of liposome
has limited its application.
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Polyamidoamine (PAMAM) dendrimers have received a
great deal of attention as a new class of gene carriers over the
past few years [15,16]. PAMAM is a nonvirus, nanometer-
sized  carrier  with  the  advantages  of  high  transfection
efficiency  and  long-term  stable  expression  without
immunogenicity or genotoxicity. In the present study, we used
the fifth generation of PAMAM (PAMAM G5) to transfect
LECs and compare its efficiency with liposome, the common
nonviral vector of gene therapy. Furthermore, we investigated
the  expression  of  cytochrome  c  and  cleaved  caspase-3  to
determine whether the apoptosis was induced through the
mitochondrial pathway [17,18].
METHODS
Small hairpin RNA preparation and plasmid construction:
Two pairs of shRNA were designed according to the bcl-2
sequence  in  GenBank  (NM_000633),  mainly  following
Tuschl’s rules [19]. The sequence was transcribed with the
DNA  polymerase  III  U6  promoter  in  plasmid  pGCsi
purchased from GeneChem Co. Ltd. (Shanghai, China). The
plasmid pGCsi carries the GFP (green fluorescent protein)
gene. In our previous study, we confirmed that both of them
could successfully inhibit the expression of bcl-2 in HLECs
[14]. In the present study, we use one of these shRNAs, called
bcl-2 shRNA. Its forward sequence is: 5′-GAT CCC AAG
TGA AGT CAA CAT GCC TGC TTC AAG AGA GCA GGC
ATG TTG ACT TCA CTT TTT TT-3′.
Cell culture and transfection with the small hairpin RNA
expression  vector:  SRA01/04  cells  (a  HLEC  line)  were
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74cultured in DMEM medium supplemented with 10% fetal
bovine  serum,  2.05  mmol/l  L-glutamine,  100  U/ml  of
penicillin  and  100  μg/ml  streptomycin  at  37  °C,  and  5%
CO2. For transfection, the cells were seeded in six-well plates
at 1×106 cells/well and allowed to grow overnight to 90%–
95% confluency. In the PAMAM group, they were transfected
with the mixture of 2 μg plasmid DNA and 12 μg PAMAM
G5  (Sigma-Aldrich,  St.  Louis,  MO)  in  2  ml  serum-free
medium. In the liposome group, they were transfected with a
mixture of 2 μg plasmid DNA and 4 μl LipofectamineTM 2000
(Invitrogen, Carlsbad, CA) in 2 ml serum-free medium. At 6
h  after  transfection,  the  medium  was  replaced  by  normal
medium containing 10% fetal bovine serum and antibiotics up
to 48 h after transfection. In addition to the medium control,
cells were transfected with negative control shRNA.
Detection of transfection efficiency: At 24, 48, and 72 h after
transfection, the samples were digested and centrifuged at
20,000×  g  for  10  min.  After  removing  the  supernatant,
200 μl of buffer was added and analyzed by flow cytometry.
The  difference  in  transfection  efficiency  between  the
PAMAM group and the liposome group at different times was
compared. Transfected cells are green under a fluorescent
microscope.
Detection of Bcl-2 mRNA expression by real-time PCR: Total
RNA  from  HLECs  was  prepared  using  Trizol®  Reagent
(Invitrogen, Carlsbad, CA). cDNA synthesis was conducted
according  to  the  RNA  PCR  kit  protocol  (Takara,  Dalian,
China).  The  GAPDH  (glyceraldehyde  3-phosphate
dehydrogenase) gene was used as a normalizing control. The
designed paired primers were as follows: bcl-2, 5′-CAT CTC
TGT TTT CTG GCC ACA-3′ (forward), 5′-ATC CTC CTC
AGA AAC AGC AGC-3′ (reverse); GAPDH, 5′-ACC ACA
GTC CAT GCC ATC AC-3′ (forward), 5′-TCC ACC ACC
CTG  TTG  CTG  TA-3′  (reverse).  The  PCR  reaction  was
performed  in  a  volume  of  20  µl  using  SYBR  green  mix
(Takara,  Dalian,  China)  on  an  MXP3000  instrument
(Stratagene Laboratories, La Jolla, CA). PCR results were
analyzed using Opticon Monitor Analysis 2.0 software (Bio-
Rad  Laboratories,  Inc.,  Hercules,  CA).  Each  sample  was
tested at least three times.
Detection of Bcl-2 protein expression by western blot: Cells
were lysed in a buffer containing 50 mmol/l Tris-HCl, pH 8.0,
150 mmol/l NaCl, 100 μg/ml phenylmethylsulfonyl fluoride,
and  1%  TritonX-100.  Total  protein  in  cell  lysates  was
measured  with  the  Bio-Rad  colorimetric  kit.  Here,  50  μg
protein  lysate  was  separated  by  12%  SDS–PAGE  and
Figure  1.  Human  lens  epithelial  cells
were  transfected  successfully  with
polyamidoamine(PAMAM)  and
liposome.  At  48  h  after  transfection,
green (transfected) cells could be seen
in  the  PAMAM  group  (A),  liposome
group (B) and negative control group
(C)  under  fluorescent  microscope
(10×20),  while  there  was  almost  no
green cell in the empty control group
(D).The  transfection  rate  of  the
PAMAM group and liposome group at
24, 48, and 72 h after transfection were
compared (E).
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75transferred onto polyvinylidene fluoride. After blocking in a
10% nonfat dry milk solution in washing buffer containing 10
mmol/l  Tris  (pH  7.6),  150  mmol/l  NaCl,  and  0.05%
Tween-20,  membranes  were  incubated  for  1  h  at  room
temperature  with  mouse  monoclonal  IgG1  of  anti-bcl-2
(sc-7382; Santa Cruz Biotechnology, Santa Cruz, CA). Then
they were washed four times and further incubated for 1 h with
goat  antimouse  horseradish  peroxidase–coupled  secondary
antibodies  (Zhongshan  Golden  Bridge  Biotechnology,
Beijing, China) at room temperature. Signals were detected
with the ECL kit (Amersham Pharmacia Biotech UK Ltd.,
Little Chalfont, UK). β-Actin staining served as the internal
standard for all membranes.
Apoptosis  assay:  Apoptotic  cells  were  measured  with  an
Annexin V/FITC kit (Bipec Biopharma, Cambridge, MA)
according to the manufacturer's instructions and analyzed by
flow cytometry at 48 h after transfection. Experiments were
conducted in triplicate. Furthermore, morphological alteration
of cell apoptosis in SRA01/04 was observed under a confocal
microscope using Hoechst 33258 (Sigma-Aldrich) staining
approach. The expression of cytochrome c and the activity of
cleaved  caspase-3  were  investigated  by  western  blot  as
mentioned above. Anti-cytochrome c (sc-13561; Santa Cruz
Biotechnology, Santa Cruz, CA) and anti-cleaved caspase-3
(sc-22171; Santa Cruz Biotechnology) were used in western
blot.
Statistical  analysis:  All  experiments  were  performed  in
triplicate. The one-way ANOVA was used to determine the
statistical significance of the data obtained. The software used
was SPSS 11.0 (SPSS for Windows, version 11.0, SPSS Inc.,
Chicago, IL). A value of p<0.05 was taken to represent a
statistically significant difference between group means.
RESULTS
Transfection efficiency: The transfection rates of the PAMAM
group and liposome group at 24, 48, and 72 h after transfection
were  42.3±2.0%,  47.7±1.8%,  48.5±1.5%,  and  35.1±1.8%,
41.1±1.7%,  42.0±2.3%,  respectively.  The  difference  was
significant  (p<0.05).  We  also  observed  the  cells  with  a
fluorescent microscope and found many green cells, which
showed that they had been transfected, in the PAMAM group,
liposome group, and negative control shRNA group; there
were almost no green cells in the empty control group (Figure
1).
Detection of bcl-2 mRNA expression by real-time PCR: Real-
time PCR showed that the bcl-2 mRNA expression of the
PAMAM group and liposome group were greatly reduced
compared with the negative control shRNA group and the
empty control group. The expression in the PAMAM group
was  significantly  lower  than  that  in  the  liposome  group
(p<0.05; Figure 2).
Detection  of  bcl-2  protein  expression  by  western  blot:
Western blot showed that the bcl-2 protein expression of the
PAMAM group and liposome group were greatly reduced
compared with the negative control shRNA group (NC group)
and the empty control group (EC group; Figure 3).
Apoptosis  assay:  The  percentage  of  HLECs  undergoing
apoptosis,  measured  by  annexin  V-FITC/PI  staining,  was
greatly improved in the PAMAM group and liposome group
Figure  2.  Bcl-2  mRNA  expression  is
suppressed by Bcl-2 shRNA. At 48 h
after  transfection,  the  relative
expression  of  Bcl-2  mRNA  was
measured  using  real-time  PCR.  The
Bcl-2  mRNA  expression  of  the
PAMAM  group  and  liposome  group
were greatly reduced compared with the
negative  control  shRNA  group  (NC
group) and the empty control group (EC
group).*  p<0.05  is  significantly
different from the liposome group.
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76at about 45.7±1.2% and 40.9±0.8%, respectively (Figure 4).
Hoechst staining showed that bcl-2 shRNA transfected cells
had a lower growth status, with nuclear fragmentation and
condensation (Figure 5). The expression of cytochrome c and
the  activity  of  cleaved  caspase-3  were  greatly  increased
(p<0.05) in these two groups (Figure 6).
DISCUSSION
The key to preventing PCO is to eradicate the residual lens
cells following surgery. In the past few years, a new strategy
was proposed to remove the residual lens cells by inducing
apoptosis.  Previous  studies  have  shown  that  Bax  (bcl-2
associated  X  protein)  or  procaspase-3  overexpression  is
capable of inducing therapeutic programmed cell death in
vitro and in vivo in residual lens cells and preventing PCO in
a rabbit model [20].
Our strategy was to remove the residua lens cells by
inducing apoptosis with RNAi. In our study, we approved that
knockdown of bcl-2 can induce the apoptosis of HLECs. As
we know, bcl-2 is a prominent member of the bcl-2 family of
proteins, which regulate the induction of apoptotic cell death
by a wide variety of stimuli. Knockdown of bcl-2 by shRNA
was able to induce apoptosis in many tumor tissues [21,22].
The present investigation showed that it could also induce
apoptosis in HLECs. The percentage of HLECs undergoing
apoptosis,  measured  by  annexin  V-FITC/PI  staining,  was
greatly improved in the PAMAM group and liposome group.
The morphological alteration of cell apoptosis could also be
observed under a confocal microscope using Hoechst 33258
staining approach. These data demonstrated that apoptosis of
HLECs was induced. The results were similar to overexpress
Figure  3.  Bcl-2  protein  expression  is
suppressed by Bcl-2 shRNA. At 48 h
after  transfection,  the  Bcl-2  protein
expression of the PAMAM group and
liposome  group  were  greatly  reduced
compared  with  the  negative  control
shRNA group (NC group) and the empty
control group (EC group).
Figure 4. Bcl-2 shRNA induced HLEC
apoptosis. Apoptosis was measured by
annexin  V-FITC/PI  staining  and
analyzed  with  flow  cytometry.
Horizontal and vertical axes represent
labeling with annexin V-FITC and PI,
respectively.  The  lower  left  indicates
live cells; the lower right shows early
apoptotic  cells.  The  upper  left  shows
necrotic  cells,  while  the  upper  right
demonstrates late apoptotic cells. The
FACS  plots  shown  were  a
representative  of  three  independent
experiments. The percentage of HLECs
undergoing  apoptosis  was  greatly
increased in the PAMAM group (A) and
liposome group (B), compared with the
negative  control  group  (C)  and  the
empty control group (D).
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77Bax or procaspase-3 using adenovirus-mediated gene transfer
[20].
In our study, the expression of cytochrome c and the
activity of cleaved caspase-3 were greatly increased. As we
know, apoptosis is induced via two main routes involving
either the mitochondria or the activation of death receptors.
The mitochondrial pathway is activated by a wide range of
signals  and  involves  the  release  of  proteins  (including
cytochrome  c)  from  the  mitochondrial  membrane  space.
Cytochrome c leads to the activation of caspase-9, which then
triggers a cascade of caspase activation (caspase-3, caspase-6,
caspase-7), resulting in the morphological and biochemical
changes  associated  with  apoptosis  [17,18].  The  present
investigation  suggest  that  the  apoptosis  is  induced  by
engaging  the  mitochondrial  pathway,  including  catalytic
activation of the caspases [20].
The difficulty of gene therapy is how to transfer the gene
into the target tissue. Viral or nonviral vectors have their own
usage  in  different  conditions  [23-28].  PCO  is  not  life
threatening; therefore, the use of potentially harmful viral
vectors  is  questionable.  Nonviral  vectors  have  potential
advantages. Most of them are safe and nontoxic to ocular
tissues. The major drawback of nonviral vectors is their low
transfection rate and relatively short life. Over the past few
years, PAMAM has emerged as a new class of nanoscopic,
spherical  polymers  that  have  captured  the  interest  of
researchers in various scientific disciplines [29-31]. Here, in
a comparison between PAMAM and liposome, we found that
PAMAM had higher transfection efficiency than liposome.
Figure 5. Bcl-2 shRNA induced HLECs
apoptosis. Apoptosis was observed by
Hoechst  33258  staining  (original
magnification 40×). After human lens
epithelial  cells  (HLECs)  were
transfected  for  48  h,  marked
morphological  changes  were  clearly
seen on Hoechst 33258 staining in the
PAMAM group (A) and the liposome
group (B), compared with the negative
control group (C) and the empty control
group (D). The changes were suggestive
of apoptosis, including condensation of
chromatin, nuclear fragmentations, and
apoptotic bodies. Scale bar, 20 µm.
Figure  6.  Western  blot  analysis  of
cytochrome  c  and  cleaved  caspase-3
protein. At 48 h after transfection, the
cells were harvested and processed for
western blotting. β-Actin was used as
the  internal  control.  The  immunoblot
was  a  representative  of  three
independent  experiments.  The
expression  of  cytochrome  c  and  the
activity  of  cleaved  caspase-3  were
greatly  improved  (p<0.05)  in  the
PAMAM  group  and  liposome  group,
compared  with  the  negative  control
group and the empty control group.
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78Considering its safety and multifunctionality, it appears to
have bright prospects in gene therapy.
In summary, we have shown that bcl-2 shRNA can inhibit
the expression of bcl-2 in HLECs and induce cell apoptosis
by engaging the mitochondrial pathway, including catalytic
activation of the caspases. Further work is needed to restrict
RNAi  to  the  remaining  HLECs  and  avoid  harming
neighboring normal tissues such as the cornea and iris before
this approach can be used for the treatment of human disease.
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